State of Alaska Department of Revenue’s Xeris Biopharma Holdings XERS Stock Holding History

State of Alaska Department of Revenue’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66K	Hold	8,457	–	–	﹤0.01%	1875
2026 Q1	$49K	Hold	8,457	–	–	﹤0.01%	1908
2025 Q4	$66K	Hold	8,457	–	–	﹤0.01%	1862
2025 Q3	$68K	Buy	+8,457	New	+$56.2K	﹤0.01%	1736

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DMKJ

David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

State of Alaska Department of Revenue's XERS Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 8,457 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

State of Alaska Department of Revenue first reported a position in XERS in Q3 2025 and has held it in 4 quarters since. The position peaked at $68K in Q3 2025. 126 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

State of Alaska Department of Revenue held 8,457 shares of Xeris Biopharma Holdings worth $66K as of Q2 2026.
State of Alaska Department of Revenue left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
Xeris Biopharma Holdings made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1875 holding.
State of Alaska Department of Revenue first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 4 quarters since.
State of Alaska Department of Revenue's Xeris Biopharma Holdings position peaked at $68K in Q3 2025.
126 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.